Streetbeat News

Price Targets

ADBE

In the last quarter, Adobe (NASDAQ:ADBE) received 4 bullish, 9 somewhat bullish, and 7 indifferent analyst ratings. The average 12-month price target for Adobe is $498.95, with a high of $600.00 and a low of $415.00, increasing by 16.97% over the past month.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 7:02 pm

LLY

In the last quarter, Eli Lilly (NYSE:LLY) received 2 bullish, 18 somewhat bullish, and 1 indifferent rating from analysts. The average 12-month price target for the company is $459.9, up 9.2% from the previous average of $421.16.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 7:02 pm

MOH

In the last quarter, Molina Healthcare (NYSE:MOH) received 1 bullish, 3 somewhat bullish, 4 indifferent, and 1 somewhat bearish analyst ratings. The average 12-month price target is $340.89, a 3.07% decrease from the previous average of $351.67.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 7:01 pm

CYTK

In the last 3 months, 11 analysts have provided 12-month price targets for Cytokinetics (NASDAQ:CYTK), with an average price target of $56.82, a 6.24% decrease from the previous average of $60.60. The ratings include 7 bullish, 4 somewhat bullish, and no bearish opinions.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 7:00 pm

ABBV

RGNX

SRPT

Baird has initiated coverage on RegenXbio Inc (NASDAQ:RGNX) with an Outperform rating and a price target of $42, citing potential gains from AAV gene therapies resurgence. The analyst believes RegenXbio can be a leader in the AAV gene therapy space and that the market underappreciates the opportunity for its partnered ABBV-RGX-314 with AbbVie Inc (NYSE:ABBV). Regenx could also compete with Sarepta Therapeutic Inc's (NASDAQ:SRPT) SRP-9001 in the DMD market.

Portfolio Pulse from Vandana Singh

June 20, 2023 | 6:43 pm

ACVA

Needham analyst Chris Pierce reiterated a Buy rating on ACV Auctions Inc. (NASDAQ:ACVA) and raised the price target to $23 from $20. ACVA is gaining momentum in the Upper Midwest, and dealer hesitancy to transact digitally has decreased. This could lead to market share gains for the company in multiple cities in the region.

Portfolio Pulse from Nabaparna Bhattacharya

June 20, 2023 | 6:34 pm

BAC

Unusual options activity has been observed in Bank of America (NYSE:BAC), with 24 uncommon trades spotted, including 7 puts and 17 calls. The overall sentiment is split between 54% bullish and 45% bearish. Whales have been targeting a price range of $15.0 to $37.0 for BAC over the last 3 months. Citigroup maintains a Neutral rating on BAC with a price target of $31.

Portfolio Pulse from Benzinga Insights

June 20, 2023 | 6:16 pm

SHOP

Oppenheimer analyst Ken Wong raised Shopify's (NYSE:SHOP) price target to $80 from $70 with an Outperform rating, citing stronger margins and EBIT in FY24. The analyst is bullish on the company's strategic shift and expects total operating expense savings of around $750 million.

Portfolio Pulse from Lekha Gupta

June 20, 2023 | 6:13 pm

COHR

MIELF

Needham analyst Jim Ricchiuti reiterated a Buy rating on Coherent Corp. (NYSE:COHR) and nearly doubled the price target to $64 from $33. The company is expected to benefit from long-term recovery of network business and strength in industrial markets, boosted by AI. Coherent's recent MOU with Mitsubishi Electric Corp (OTC:MIELF) and the acquisition of Finisar are also seen as positive factors.

Portfolio Pulse from Nabaparna Bhattacharya

June 20, 2023 | 6:03 pm

ESI

BMO Capital Markets analyst Bhavesh Lodaya initiated coverage of Element Solutions Inc (NYSE:ESI) with an Outperform rating and a price target of $23. Lodaya is bullish on the company's diversified offerings, low capital intensity, and high cash flow generation, expecting ESI to benefit from 5G, semiconductors, and EV market growth.

Portfolio Pulse from Lekha Gupta

June 20, 2023 | 6:01 pm